Milestone Pharmaceuticals Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -49.97M-42.85M
Depreciation and Depletion 0.09M0.09M0.09M0.10M
Share-based Compensation 0.63M1.19M4.95M7.28M9.05M9.53M5.78M
Gains from Investment Securities 5.75M-0.14M-0.01M
Non-cash Items 11.70M
Cash from Operations -21.05M-51.15M-50.73M-33.22M-52.47M-46.42M-28.85M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 2.31M3.21M
Depreciation & Amortization (CF) 0.01M0.04M0.10M0.09M0.09M0.09M0.10M
Change in Working Capital
Change in Receivables 0.27M-0.12M-0.04M-0.10M0.76M2.33M-1.72M
Change in Accured Expenses 2.88M3.52M-2.08M0.64M-0.91M1.04M0.88M
Change in Taxes 0.05M-0.06M
Other Working Capital Changes 1.30M0.45M3.58M-1.13M1.71M-2.83M-1.34M
Investing Activities
Capital Expenditures 0.01M0.41M0.27M0.11M0.03M
Change in Acquisitions & Divestments 19.03M35.03M20.00M85.00M29.00M
Cash from Investing Activities 16.00M-0.38M-70.00M70.00M-57.12M4.76M8.28M
Financing Activities
Other financing activities 2.78M
Cash from Financing Activities 80.11M85.41M73.22M5.05M3.09M47.79M32.12M
Additional items
Change in Cash 75.07M33.87M-47.51M41.83M-106.50M6.12M11.55M
Free Cash Flow -21.05M-51.56M-50.73M-33.22M-52.74M-46.54M-28.88M
Net Cash Flow 75.07M33.87M-47.51M41.83M-106.50M6.12M11.55M